点击上方关注我们
当前，生物仿制药俨然已成为业界热议的话题。根据生物医药产业情报服务平台（biomed.tisti.ac.cn）的数据检索结果，截至2015年3月10日，全球共有583个生物仿制药在研或上市品种，其中已上市品种50个。下面，我们将继续上一期，对余下25个品种的基本信息进行概览。
| 药物名称 | 企业名称 | 适应症 | 作用机制 |
| Epolyrec | Recpharma | Anemia | Erythropoietin ligand; Erythropoietin receptor agonist |
| erythropoietin biosimilar, Stada | Hemofarm AD; NOBEL ILAC Sanayii ve Ticaret AS; Stada Arzneimittel AG | Anemia | Erythropoietin ligand |
| filgrastim biosimilar, CT Arzneimittel | CT Arzneimittel GmbH | Neutropenia | GCSF ligand; GCSF receptor agonist |
| reteplase biosimilar, Shandong Ahua Biochemical | Shandong Ahua Biochemical Co Ltd | Myocardial infarction | Plasminogen activator stimulator; Unspecified enzyme stimulator |
| rituximab biosimilar, Intas Biopharmaceuticals | Intas Biopharmaceuticals | Hematological disease; Rheumatoid arthritis | B-lymphocyte antigen CD20 inhibitor |
| teriparatide biosimilar, Intas Pharmaceuticals | Intas Pharmaceuticals Ltd | Osteoporosis | Parathyroid hormone receptor agonist |
| filgrastim biosimilar, Fuji Pharma/Gene Techno Science/Mochida | Fuji Pharma Co Ltd; Gene Techno Science Co Ltd; Mochida Pharmaceutical Co Ltd | Neutropenia | GCSF ligand; GCSF receptor agonist |
| insulin follow-on biologic, Biocon | Bayer AG; Biocon Ltd | Diabetes mellitus | Insulin ligand; Insulin receptor agonist |
| molgramostim biosimilar API, Reliance GeneMedix | Reliance GeneMedix plc | Leukopenia | GM-CSF receptor agonist |
| filgrastim biosimilar, Reliance Life Sciences/Reliance GeneMedix | Reliance GeneMedix plc; Reliance Life Sciences Group | Neutropenia | GCSF ligand; GCSF receptor agonist |
| epoetin alfa biosimilar, Reliance GeneMedix | Reliance GeneMedix plc; Reliance Life Sciences Group | Anemia | Erythropoietin ligand |
| thrombopoietin biosimilar, Biolotus Biotech | Biolotus Biotech | Thrombocytopenia | Thrombopoietin ligand |
| darbepoetin alfa biosimilar, PanPharmaceuticals | PanPharmaceuticals USA Inc | Anemia | Erythropoietin ligand |
| filgrastim follow-on biologic, Emcure | Emcure Pharmaceuticals Ltd | Neutropenia | GCSF ligand; GCSF receptor agonist |
| sargramostim biosimilar, Emcure | Emcure Pharmaceuticals Ltd | Neutropenia | CSF-1 agonist; GM-CSF receptor agonist |
| interferon beta-1b biosimilar, Biocad | Biocad Ltd | Multiple sclerosis | Interferon beta ligand |
| peginterferon alfa 2b biosimilar, PanPharmaceuticals | PanPharmaceuticals USA Inc | Hepatitis C virus infection | Interferon alpha 2 ligand |
| peginterferon alfa 2a biosimilar, PanPharmaceuticals | PanPharmaceuticals USA Inc | Hepatitis C virus infection | Interferon alpha 2 ligand |
| dibotermin alfa biosimilar, Cowellmedi | Cowellmedi Co Ltd | Bone disease | Bone morphogenetic protein-2 ligand |
| peginterferon alfa-2a follow-on biologic, Rhein-Minapharm | C-Pharma; Rhein-Minapharm | Hepatitis C virus infection | Interferon alpha 2 ligand |
| rasburicase biosimilar, Virchow | Virchow Group | Hyperuricemia; Tumor lysis syndrome | Uricase stimulator |
| interferon alfa-2b biosimilar, Virchow | Virchow Group | Hepatitis B virus infection; Hepatitis C virus infection | Interferon alpha 2 ligand |
| filgrastim biosimilar, PanPharmaceuticals | PanPharmaceuticals USA Inc | Neutropenia | GCSF ligand; GCSF receptor agonist |
| pegfilgrastim biosimilar, PanPharmaceuticals | PanPharmaceuticals USA Inc | Neutropenia |
GCSF receptor agonist |
| Alfarona | PHARMACLON LLC | Acute lymphoblastic leukemia; Bacterial infection; Basal cell carcinoma; Chronic myelocytic leukemia; Conjunctivitis; Hairy cell leukemia; Hepatitis B virus infection; Hepatitis C virus infection; Hepatitis D virus infection; Jaundice; Kaposis sarcoma; Keratoconjunctivitis; Metastatic renal cancer; Multiple sclerosis; Mycoplasma infection; Papillomavirus infection; Skin cancer; Skin lymphoma; Squamous cell carcinoma; Thrombocytopenia |
联系客服
